FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

DGX

Quest DiagnosticsNYSE · Health Care Services · Health Care
Previous close
247.08
Change
0.00 / 0.00%
FinDog View
Neutral
52-Week Range
171.18 – 248.65
P/E (TTM)
25.7
Forward P/E
20.1
Based on consensus earnings for the next 12 months
Market Cap
$27.3B
1M
+4.91%
S&P 500 −2.41% over same period
Volume / Avg Volume
948K / 989K
0.96× average

Price History

Closing price · USD1M6M1Y5Y
100150200250FY26 Q2 EarningsFY26 Q1 EarningsFY25 Q4 EarningsFY25 Q3 EarningsFY25 Q2 EarningsFY25 Q1 Earnings2021-092022-122024-032025-062026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 21.31M6M1Y5Y
1517.52022.52527.52023-082024-052025-032025-122026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 97 of its 5-year rangeExpensive
5-year range 17.4 – 24.6 · Median 21.3
Last 4 quarters: $450M in buybacks + $363M in dividends, 2.98% of market cap combined
P/E (TTM)
25.7
P/B
3.6
P/S
2.4
Dividend Yield
2.10%
Earnings Reaction
Over the last 6 reports, the stock moved ±1.7% on average on the first trading day after, rising 2 times
Most recent −0.02%
Volatility & Correlation
1-year beta -0.13 · Correlation with S&P 500 -0.07Low beta
Annualized volatility 24% vs. 13% for the S&P 500
Insider Trading
View all
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 3 · $8.3MNet selling $8.3M
  • 09-01Davis J. E.CEO and PresidentSell$2.4M10,000 shares · Avg price 242.72
  • 08-28PREVOZNIK MICHAEL ESVP & General CounselSell$5.5M22,677 shares · 3 trades · Avg price 243.11
  • 07-28DELANEY MARK ESVP & Chief Commercial OfficerSell$0.38M1,600 shares · Avg price 235.18
Multi-Quarter Financial Trends
View all quarters
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q23.04+10.2%33.7%0.460.320.462.84
FY2026 Q12.90+9.2%32.5%0.400.250.162.24
FY2025 Q42.81+7.1%32.4%0.390.250.312.18
FY2025 Q32.82+13.2%33.7%0.390.250.422.16
FY2025 Q22.76+15.2%34.2%0.440.280.442.47
FY2025 Q12.65+12.1%32.5%0.350.220.201.94
FY2024 Q42.62+14.6%32.7%0.360.220.341.95
FY2024 Q32.49+8.4%32.6%0.330.230.251.99
FY2024 Q22.40+2.5%33.5%0.360.230.272.03
FY2024 Q12.37+1.5%32.6%0.300.190.051.72
FY2023 Q42.29−1.9%32.2%0.270.190.461.70
FY2023 Q32.30−7.7%32.9%0.340.230.101.96

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView